A phase 2 liver trial where the add-on drug didn't help — and the base drug quietly did
Read the Sunday Brief →

Study wrapper · #636

Selank Inhibits Ethanol-Induced Hyperlocomotion and Manifestation of Behavioral Sensitization in DBA/2 Mice.

Kolik LG, Nadorova AV, Seredenin SB Bulletin of experimental biology and medicine. 2016.
Weak / noneAnimal (in vivo)Mentions: Selank

Editor's note

This is a preclinical mouse study examining Selank's effect on alcohol-related behavior. In male DBA/2 mice, researchers reported that Selank (0.3 mg/kg i.p.) — like the opioid-receptor blocker naloxone — was associated with blocking ethanol-induced hyperlocomotion, whereas the sigma-1 agonist Afobazole was not. A single dose of Selank also blocked the expression of behavioral sensitization to ethanol without affecting its formation. The authors frame Selank as acting via the endogenous opioid system to modulate the motivational effects of ethanol. For Selank, this adds an opioid-linked mechanism to its anxiolytic profile and connects to a small rodent literature on alcohol withdrawal. Weigh it as one behavioral dataset: it uses a single mouse strain and locomotor endpoints as proxies for 'motivational' effects, with mechanism inferred from a comparison to naloxone. These are preclinical findings; human data are needed before clinical conclusions can be drawn.

Plain-language abstract

Alcohol makes mice more active in a way researchers can measure, and this over-activity can grow stronger with repeated exposure (a process called sensitization). Scientists used this model to test whether Selank changes how mice respond to alcohol. In male mice of one strain, a single injection of Selank blocked the burst of extra movement that alcohol normally caused — the same result seen with naloxone, a drug that blocks opioid receptors. Another compound that acts on a different target did not have this effect. Selank also blocked the strengthened response in mice that had already been sensitized, without stopping that sensitization from forming. Because Selank behaved like the opioid-blocker, the authors suggest it works partly through the body's natural opioid system to dampen alcohol's motivating effects. This was a study in one strain of mice using activity as the main measure, not evidence about alcohol use in people.